Urolithin a attenuates rheumatoid arthritis by inhibiting inflammation and pyroptosis in fibroblasts via the AMPK/ NF-κB signaling pathway
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114604 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Hao Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang University School of Medicine, Hangzhou First People's Hospital, Hangzhou 310006, China. Hauptthemen laut MEDLINE: Coumarins, Arthritis, Rheumatoid, Fibroblasts, Arthritis, Experimental. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Zhejiang University, Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Urolithin A (UA), a metabolite of natural polyphenols produced by the gut microbiota, alleviates the symptoms of rheumatoid arthritis (RA) by inhibiting the inflammatory response. UA alleviates the clinical symptoms of RA by inhibiting the occurrence of an inflammatory response, but the specific regulatory mechanism remains unclear. In this study, we established a CIA model in 8-week-old DBA mice and chose LPS-stimulated NIH/3 T3 cells to explore the effects of UA and attempted to elucidate its potential mechanisms. Our results showed UA significantly reduced arthritis scores, and inhibited inflammation, pannus formation, and cartilage and bone destruction of inflamed joints in CIA mice. In vitro, UA inhibited LPS-induced migration and proliferation, and alleviated NLRP3-mediated pyroptosis, significantly inhibiting the protein expression levels of NLRP3, N-terminal gasdermin D, interleukin-1β, caspase-1, and ASC in NIH/3T3 cells. A mechanistic investigation revealed that LPS enhanced phosphorylation of NF-κB and downregulated that of AMPK, which were categorically counteracted by UA treatment. Therefore, UA represents a new class of promising RA treatments targeting fibroblasts, widening the therapeutic options for RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang University School of Medicine, Hangzhou First People's Hospital, Hangzhou 310006, China.
- Department of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China. Electronic address: zhangzhen9714@zju.edu.cn.
- The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou 310006, China.
- Department of Orthopedic Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China. Electronic address: limaoqiangzhong@126.com.
- Department of Orthopedic Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China. Electronic address: zhuliulong@zju.edu.cn.
Förderung
- Zhejiang University
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Chen, H., Zhang, Z., Lu, C., Ding, Y., Huang, Z., Li, M., & Zhu, L. (2025). Urolithin a attenuates rheumatoid arthritis by inhibiting inflammation and pyroptosis in fibroblasts via the AMPK/ NF-κB signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114604
Vancouver
Chen H, Zhang Z, Lu C, Ding Y, Huang Z, Li M, et al. Urolithin a attenuates rheumatoid arthritis by inhibiting inflammation and pyroptosis in fibroblasts via the AMPK/ NF-κB signaling pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114604
BibTeX
@article{Chen2025,
author = {Chen, Hao and Zhang, Zhen and Lu, Congcong and Ding, Yi and Huang, Zhengao and Li, Maoqiang and Zhu, Liulong},
title = {Urolithin a attenuates rheumatoid arthritis by inhibiting inflammation and pyroptosis in fibroblasts via the AMPK/ NF-κB signaling pathway},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114604}
}
EUVIMED